These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 6988183)
1. In vitro synergism between tetracyclines and antimalarials. Toama MA Chemotherapy; 1980; 26(3):191-5. PubMed ID: 6988183 [TBL] [Abstract][Full Text] [Related]
2. [Tetracyclines: bacteriostatic or bactericidal drugs? In vitro studies with rolitetracycline, minocycline and doxycycline (author's transl)]. Daschner F Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):527-34. PubMed ID: 345688 [TBL] [Abstract][Full Text] [Related]
3. [Antibacterial activity of minocycline alone and associated with other antibiotics (author's transl)]. Joly BH; Sirot JL; Cluzel MG Pathol Biol (Paris); 1976 Apr; 24(4):257-64. PubMed ID: 778758 [TBL] [Abstract][Full Text] [Related]
4. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)]. Shah PM; Stille W Arzneimittelforschung; 1978; 28(9):1539-41. PubMed ID: 383106 [TBL] [Abstract][Full Text] [Related]
5. [Increase in tetracycline activity by using surface-active substances]. Anan'eva EP; Afinogenov GE; Elinov NP Antibiotiki; 1978 Jul; 23(7):605-9. PubMed ID: 98103 [TBL] [Abstract][Full Text] [Related]
6. Synergistic interactions between cefalexin and kanamycin in Mueller-Hinton broth medium and in milk. Ganière JP; Denuault L J Appl Microbiol; 2009 Jul; 107(1):117-25. PubMed ID: 19302331 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of the activity of novobiocin against Escherichia coli by lactoferrin. Sanchez MS; Watts JL J Dairy Sci; 1999 Mar; 82(3):494-9. PubMed ID: 10194666 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens. Al-Ani I; Zimmermann S; Reichling J; Wink M Phytomedicine; 2015 Feb; 22(2):245-55. PubMed ID: 25765829 [TBL] [Abstract][Full Text] [Related]
9. Bacterial sensitivity to minocycline (minocin) of clinical isolations. Wamola IA; Slack RC East Afr Med J; 1977 Nov; 54(11):658-60. PubMed ID: 95945 [No Abstract] [Full Text] [Related]
11. Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Oliva B; Chopra I Antimicrob Agents Chemother; 1992 Apr; 36(4):876-8. PubMed ID: 1503452 [TBL] [Abstract][Full Text] [Related]
12. Novel combinations of antibiotics to inhibit extended-spectrum β-lactamase and metallo-β-lactamase producers in vitro: a synergistic approach. Hasan S; Ali SZ; Khan AU Future Microbiol; 2013 Jul; 8(7):939-44. PubMed ID: 23841638 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacokinetic characteristics and the chemotherapeutic effectiveness of a 2% ditetracycline-erythromycin eye ointment]. Vasil'ev VK; Bodunkova LE; Kagan EZ; Druzhinina EN; Suvorkina DV Antibiotiki; 1976 Mar; 21(3):238-42. PubMed ID: 776076 [TBL] [Abstract][Full Text] [Related]
14. In vitro antimicrobial interactions of arthemeter with some 4-quinolones. Esimone CO; Adikwu MU; Nwafor SV; Okoli CO; Ndu OO; Nwoke OI Boll Chim Farm; 2002; 141(5):385-8. PubMed ID: 12481382 [TBL] [Abstract][Full Text] [Related]
15. Iron blocks the accumulation and activity of tetracyclines in bacteria. Avery AM; Goddard HJ; Sumner ER; Avery SV Antimicrob Agents Chemother; 2004 May; 48(5):1892-4. PubMed ID: 15105154 [TBL] [Abstract][Full Text] [Related]
16. Activity of Eravacycline against Escherichia coli Clinical Isolates Collected from U.S. Veterans in 2011 in Relation to Coresistance Phenotype and Sequence Type 131 Genotype. Johnson JR; Porter SB; Johnston BD; Thuras P Antimicrob Agents Chemother; 2015 Dec; 60(3):1888-91. PubMed ID: 26666925 [TBL] [Abstract][Full Text] [Related]
17. [Bacteriostatic effect of tetracyclines-macrolides associations]. de Lajudie P Pathol Biol (Paris); 1971; 19(11):607-12. PubMed ID: 4397549 [No Abstract] [Full Text] [Related]
18. Bactericidal effect of combinations of antibiotic and antineoplastic agents against Staphylococcus aureus and Escherichia coli. Nyhlén A; Ljungberg B; Nilsson-Ehle I; Odenholt I Chemotherapy; 2002 May; 48(2):71-7. PubMed ID: 12011538 [TBL] [Abstract][Full Text] [Related]
19. Time-kill studies and synergy testing of broad-spectrum antibiotics against blood culture isolates. Arpi M Chemotherapy; 1988; 34(5):393-400. PubMed ID: 3180908 [TBL] [Abstract][Full Text] [Related]
20. Reversal of resistance in bacteria underlies synergistic effect of essential oils with conventional antibiotics. Lahmar A; Bedoui A; Mokdad-Bzeouich I; Dhaouifi Z; Kalboussi Z; Cheraif I; Ghedira K; Chekir-Ghedira L Microb Pathog; 2017 May; 106():50-59. PubMed ID: 27815129 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]